Overview
Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.
Eligibility
Inclusion Criteria:
- All patients treated at the study sites, signed informed consent
Exclusion Criteria:
- No consent to record medical history